Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYCR1 | P32322 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.34 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | TNF | P01375 | 1/20 | 0.34 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.34 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12422802 | 0.78 | CYP2C19 (0.44) | RAB9ANPC1LMNASMN1; SMN2MEN1 | |
| SCHEMBL12422835 | 0.74 | CYP2C19 (0.49) | RAB9ANPC1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL12422791 | 0.71 | G6PC1 (0.43) | MEN1KMT2A | |
| SCHEMBL13580061 | 0.70 | MEN1 (0.34) | HTTLMNAMEN1KMT2AMAPT | |
| SCHEMBL12422795 | 0.69 | ALDH1A1 (0.40) | RAB9ANPC1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL4967804 | 0.69 | PYCR1 (0.53) | PYCR1RAB9ANPC1HTTLMNA | |
| SCHEMBL6546078 | 0.68 | RAB9A (0.43) | RAB9ANPC1GRIN2BHTTLMNA | |
| SCHEMBL30919501 | 0.68 | PYCR1 (0.45) | PYCR1RAB9ANPC1HTTSLC6A2 | |
| SCHEMBL28638353 | 0.68 | RAB9A (0.54) | RAB9ANPC1GRIN2BHTTLMNA | |
| SCHEMBL14174917 | 0.68 | PYCR1 (0.51) | PYCR1HTTLMNASLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7977020-B2 | Electrophotographic photoreceptor containing enamine compound, image formation apparatus provided with the same, enamine compound and method for producing the same | SHARP KABUSHIKI KAISHA (JP) | 2011-07-12 | — | — | US | disclosed |
| US-7977020-B2 | Electrophotographic photoreceptor containing enamine compound, image formation apparatus provided with the same, enamine compound and method for producing the same | SHARP KABUSHIKI KAISHA (JP) | 2011-07-12 | — | — | US | disclosed |
| US-20080286671-A1 | Electrophotographic photoreceptor containing enamine compound, image formation apparatus provided with the same, enamine compound and method for producing the same | SHARP KABUSHIKI KAISHA (JP) | 2008-11-20 | — | — | US | disclosed |
| US-20080286671-A1 | Electrophotographic photoreceptor containing enamine compound, image formation apparatus provided with the same, enamine compound and method for producing the same | SHARP KABUSHIKI KAISHA (JP) | 2008-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080286671-A1 | Electrophotographic photoreceptor containing enamine compound, image formation apparatus provided with the same, enamine compound and method for producing the same | SLC1A2, SLC1A1, SLC18A1 | PYCR1 2011/4885RAB9A 1379/4885NPC1 1611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.